|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Other accounts receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Loan to an affiliate (note 3) | |||||||||||||||||||
| Convertible loan to an affiliate (Note 3b) | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Non-current assets: | |||||||||||||||||||
| Intangible assets, net (Note 4) | |||||||||||||||||||
| Loan to an affiliate (Note 4b) | |||||||||||||||||||
| Goodwill (Note 3) | |||||||||||||||||||
| Fixed assets, net | |||||||||||||||||||
| Investment in an affiliate (Note 3c) | |||||||||||||||||||
| Loan to an affiliate (Note 4) | |||||||||||||||||||
| Loan to an affiliate (Note 3b) | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total non-current assets | |||||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||||
| LIABILITIES & STOCKHOLDERS’ EQUITY | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Other current liabilities | |||||||||||||||||||
| Receipt on account of shares | |||||||||||||||||||
| Short term loans | |||||||||||||||||||
| Payables to related parties (Note 5) | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total payables to related parties (Note 5) | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Non-current liabilities: | |||||||||||||||||||
| Deferred revenues | |||||||||||||||||||
| Deferred tax liability (Note 3) | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity (Note 6) | |||||||||||||||||||
| Common stock, par value $0.0001, 50,000,000 shares authorized, 11,246,252 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Receipt on account of shares | |||||||||||||||||||
| Reserve from share-based compensation transactions | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity attributable to the Company | |||||||||||||||||||
| Non-controlling interests | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||||
Loading...
